Clinical Trial Update: A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a randomized controlled trial comparing lapatinib versus trastuzumab for HER2-positive breast cancer in Phase 2/Phase 3, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Tykerb (lapatinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: HER2-positive Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN